Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors

As set out in paragraph C.05.010(b) of the Food and Drug Regulations (FDR), clinical trials must follow certain requirements of the protocol. Health Canada authorizes this protocol and the Research Ethics Board approves it. During the pandemic, there may be more deviations from the established protocol.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2022-06-07

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data